The neuropathological profile of mild cognitive impairment (MCI): a systematic review
- 6 December 2011
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 17 (11) , 1056-1076
Abstract
Whether mild cognitive impairment (MCI) has a distinct neuropathological profile that reflects an intermediate state between no cognitive impairment and dementia is not clear. Identifying which biological events occur at the earliest stage of progressive disease and which are secondary to the neuropathological process is important for understating pathological pathways and for targeted disease prevention. Many studies have now reported on the neurobiology of this intermediate stage. In this systematic review, we synthesize current evidence on the neuropathological profile of MCI. A total of 162 studies were identified with varied definition of MCI, settings ranging from population to specialist clinics and a wide range of objectives. From these studies, it is clear that MCI is neuropathologically complex and cannot be understood within a single framework. Pathological changes identified include plaque and tangle formation, vascular pathologies, neurochemical deficits, cellular injury, inflammation, oxidative stress, mitochondrial changes, changes in genomic activity, synaptic dysfunction, disturbed protein metabolism and disrupted metabolic homeostasis. Determining which factors primarily drive neurodegeneration and dementia and which are secondary features of disease progression still requires further research. Standardization of the definition of MCI and reporting of pathology would greatly assist in building an integrated picture of the clinical and neuropathological profile of MCI.Keywords
This publication has 219 references indexed in Scilit:
- Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairmentBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease ProgressionBiological Psychiatry, 2010
- Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: An investigation on the role of cellular stress response in the progression of Alzheimer diseaseBrain Research, 2010
- Cell “Self‐Eating” (Autophagy) Mechanism in Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Cortical α7 Nicotinic Acetylcholine Receptor and β-Amyloid Levels in Early Alzheimer DiseaseArchives of Neurology, 2009
- The neuropathology of probable Alzheimer disease and mild cognitive impairmentAnnals of Neurology, 2009
- Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesisActa Neuropathologica, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009
- Role of the Neuropathology of Alzheimer Disease in Dementia in the Oldest-OldArchives of Neurology, 2008
- Galanin – 25 years with a multitalented neuropeptideCellular and Molecular Life Sciences, 2008